A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia

A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia

Folic acid is generally used to lower homocysteine concentrations and prevent stroke and cardiovascular disease (CVD) at present. However, the efficacy of therapies that lower homocysteine concentrations in reducing the risk of CVD and stroke remains controversial. Our objective was to do a meta-ana...

Full description

Bibliographic Details
Main Authors:	Wen-Wen Wang, Xin-Shi Wang, Zeng-Rui Zhang, Jin-Cai He, Cheng-Long Xie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-08-01
Series:	Frontiers in Pharmacology
Subjects:	folic acid enalapril hypertension antihypertensive hyperhomocysteinemia meta-analysis
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00585/full

Similar Items

The role of folic acid on the hyperhomocysteinemia in the Buerger′s disease (Thromboangiitis Obliterans)
by: Ali Akbar Beigi, et al.
Published: (2014-01-01)

Folic Acid and Vitamins B12 Levels and Their Correlation in Cigarette Smoker with Hyperhomocysteinemia
by: Shahid A. Mujawar* and Vinayak W. Patil
Published: (2011-04-01)

Evaluation of platelet distribution width in hypertension with hyperhomocysteinemia
by: Gang Li, et al.
Published: (2020-01-01)

Distribution of Pharmacogenetic Polymorphisms and the Intervention Effects of Folic Acid Combined with Vitamin D in Community-based Patients with H-type Hypertension
by: PANG Aimei, GAO Wei, ZHANG Heng, PU Shuangshuang, GUO Lili, FAN Zirong, LIU Haixia, LIU Ruixia
Published: (2024-02-01)

Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double‐blind, parallel‐controlled clinical trial
by: Huihui Bao, et al.
Published: (2023-08-01)

Prevalence and clinical correlates of hyperhomocysteinemia in Chinese urban population with hypertension
by: Yayun Xu, et al.
Published: (2024-02-01)

Intervention effect of folic acid and vitamin B12 on vascular cognitive impairment complicated with hyperhomocysteinemia
by: Jiang Bo, et al.
Published: (2014-01-01)

Comparison of oxidative stress biomarkers in hypertensive patients with or without hyperhomocysteinemia
by: Gang Guo, et al.
Published: (2018-04-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Doubly bi-allelic variants of MTHFR and MTHFD1 in a Chinese patient with hyperhomocysteinemia and failure of folic acid therapy
by: Yu-Xing Liu, et al.
Published: (2023-01-01)

COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension
by: Yan Zhang, et al.
Published: (2018-01-01)

Folic Acid Attenuates Contrast-Induced Nephropathy in Patients With Hyperhomocysteinemia Undergoing Coronary Catheterization: A Randomized Controlled Trial
by: Long Peng, et al.
Published: (2021-10-01)

Epidemiological characteristics of hyperhomocysteinemia and H-type hypertension in the elderly in Beijing, China
by: Lina Ma, et al.
Published: (2017-10-01)

Prevalence of Hyperhomocysteinemia in China: A Systematic Review and Meta-Analysis
by: Boyi Yang, et al.
Published: (2014-12-01)

Prevalence of Hyperhomocysteinemia in China: An Updated Meta-Analysis
by: Yuan Zeng, et al.
Published: (2021-09-01)

Pregravidal preparation for women with hyperhomocysteinemia
by: L A Ozolinya, et al.
Published: (2013-04-01)

COGNITIVE IMPAIRMENTS IN VITAMIN B12 AND FOLIC ACID DEFICIENCIES AND HYPERHOMOCYSTEINEMIA
by: P. R. Kamchatnov, et al.
Published: (2015-05-01)

Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study
by: Jian Chen, et al.
Published: (2021-01-01)

Hyperhomocysteinemia, low vitamin B12, and low folic acid: Are risk factors of cerebral vascular thrombosis in northwest Iran?
by: Ali Akbar Taheraghdam, et al.
Published: (2016-01-01)

Enalapril and endothelial function in arterial hypertension patients of various age
by: L. I. Katelnitskaya, et al.
Published: (2005-12-01)

A Comparative Study of the Effects of Atenolol, Enalapril and Hydrochlorothiazide on Stage II Hypertension
by: Behzad Babapour, et al.
Published: (2013-09-01)

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
by: F. E. Khebodarov, et al.
Published: (2009-10-01)

COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-08-01)

Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report
by: Paolo Ruggeri, et al.
Published: (2017-12-01)

Relationship Between Hyperhomocysteinemia , Oxidative Stress And Severity Of Atherosclerosis Lesion
by: Refahi R, et al.
Published: (2005-07-01)

EVALUACIÓN FUNCIONAL CARDIOVASCULAR EN HIPERTENSOS TRATADOS CON ENALAPRIL DURANTE 6 MESES / Functional assessment in hypertensive patients treated with enalapril for 6 months
by: Francisco Rodríguez Martorell, et al.
Published: (2012-07-01)

Folic acid and its role in female reproduction
by: I V Kuznetsova, et al.
Published: (2014-08-01)

Hyperhomocysteinemia in developing age and nutritional aspects of folates: an early cardiovascular risk factor
by: Giuseppe Caramia, et al.
Published: (2016-02-01)

Association of folic acid dosage with circulating unmetabolized folic acid in Chinese adults with H-type hypertension: a multicenter, double-blind, randomized controlled trial
by: Ping Chen, et al.
Published: (2023-09-01)

Resistencia de la hiperhomocisteinemia del paciente renal al tratamiento con dosis suprafisiológicas de ácido fólico parenteral Resistance of hyperhomocysteinemia in renal patients to treatment with supra-physiological doses of parenteral folic acid
by: M. Palomares Bayo, et al.
Published: (2008-06-01)

Enalapril microhemodynamic effects in patients with essential arterial hypertension
by: L. N. Eliseeva, et al.
Published: (2005-10-01)

COMBINED AND ORGAN-PROTECTIVE ANTI-HYPERTENSION THERAPY: POSSIBILITIES OF FIXED COMBINATION OF NITRENDIPINE AND ENALAPRIL
by: A. G. EVDOKIMOVA, et al.
Published: (2016-12-01)

Administration of enalapril for preparation ofpatients with arterial hypertension to surgical interventions
by: K I Proschaev
Published: (2003-12-01)

Association between Age at Menarche and Hyperhomocysteinemia among Women in Hunan, China: A Cross-Sectional Study
by: Yi Yang, et al.
Published: (2022-06-01)

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension
by: Tiantian Zhang, et al.
Published: (2022-10-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Folic acid restores endothelial function in ACTH-induced hypertension
by: Ibrahim Elmadbouh, et al.
Published: (2016-06-01)

VARIABILITY OF GENES OF FOLATE CYCLE IN CHILDREN WITH ESSENTIAL ARTERIAL HYPERTENSION
by: V. V. Dolgikh, et al.
Published: (2012-04-01)

Enalapril alters the formation of the collagen matrix in spontaneously hypertensive rats
by: Alfredo de Souza Bomfim, et al.
Published: (2003-07-01)